Sevelamer Carbonate NDC 33342-215

NDC codes

FDA NDC Directory

Product NDC (as listed)33342-215Labeler and product segments. Claims need a package NDC.

Product NDC at billing width33342-0215Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
33342-215-56	33342021556	14 BLISTER PACK in 1 CARTON (33342-215-56) / 10 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Oct 31, 2025
33342-215-57	33342021557	180 TABLET, FILM COATED in 1 BOTTLE (33342-215-57)Marketed from Mar 13, 2026
33342-215-58	33342021558	270 TABLET, FILM COATED in 1 BOTTLE (33342-215-58)Marketed from Apr 19, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sevelamer Carbonate
Generic name (nonproprietary): sevelamer carbonate
Active ingredients: Sevelamer carbonate — 800 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Macleods Pharmaceuticals Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206100
Marketing start: Apr 19, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Phosphate Chelating Activity (Mechanism)
Identifiers: Product ID 33342-215_ad333b84-02f4-40d8-b4a8-4778fb547a0dSPL ID ad333b84-02f4-40d8-b4a8-4778fb547a0dSPL set ID 4c927d50-34a6-499b-b1c2-924d4eb73987RxCUI 749206UNII 9YCX42I8IUUPC 0333342215581, 0333342215574
Pharmacologic class: Phosphate Binder

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N433342021556 followed by a unit qualifier and the quantity

Package 33342-0215-56. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 10, 2026.

Indications (excerpt from the label)

Sevelamer carbonate tablets are indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis. Sevelamer carbonate tablets are a phosphate binder indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 206100

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206100
Product	Strength	Form · route	Labeler	Product NDC
Sevelamer Carbonate	Sevelamer carbonate 800 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	72162-2499